50
Last reporting period 30 Jun, 2023
Updated —
Last price
—
Market cap $B
0.214
Exchange
XHKG - Hong Kong Exchange
0.0015 B
Last period CFO ,USD
388%
CFO has increased in 5 years
What is CFO ?
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
See also Lansen Pharmaceutical
Company Analysis
503.HK valuation, rating, competitors, insights and company profile
Eyestock Rating
503.HK financial analysis by Eyestock methodology
Valuation
503.HK valuation using historical relative method
Statements
503.HK Income Statements, Balance Sheet and Cash Flow Statements
Dividends
503.HK dividend yield and annual dividend
Operating cash flow is the difference between the income and expenses of cash that is generated as a result of the main activities of the company.
Lansen Pharmaceutical`s CFO for the period ended 2023-06-30 is 0.0015 B USD
